BCP
SRTA icon

Berylson Capital Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Berylson Capital Partners’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-265,000
Closed -$2.78M – 32
2021
Q2 		$2.78M Hold
265,000
– – 0.62% 48
2021
Q1 		$2.73M Hold
265,000
– – 0.66% 40
2020
Q4 		$2.94M Buy
+265,000
New +$2.7M 0.5% 57

Other funds holding SRTA

HVCM
HG Vora Capital Management New York $197M AUM 17.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DRS
Deane Retirement Strategies New Orleans, Louisiana $244M AUM 18.26% 1-Year Est. Return

Berylson Capital Partners's SRTA Position: Q3 2021 in Review

Berylson Capital Partners sold out of Strata Critical Medical Inc (SRTA) in Q3 2021, closing a stake of 265,000 shares — an estimated $2.78M sold.

Berylson Capital Partners first reported a position in SRTA in Q4 2020 and held it in 3 quarters. The position peaked at $2.94M in Q4 2020. 81 funds tracked by Wall St. Rank hold SRTA as of Q3 2021.

  • Berylson Capital Partners reported no remaining Strata Critical Medical Inc position as of Q3 2021 after selling out during the quarter.
  • Berylson Capital Partners sold 265,000 Strata Critical Medical Inc shares in Q3 2021, an estimated $2.78M.
  • Berylson Capital Partners first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 3 quarters.
  • Berylson Capital Partners's Strata Critical Medical Inc position peaked at $2.94M in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2021.

Based on Berylson Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.